GEMINA TESTPOINT

Trademark usage description

computer software for use in the workplace to record, monitor, track and report covid-19 and other coronavirus related risks, or the presence of other Read More

Classification Information

Class [009]
Computer software for use in the workplace to record, monitor, track and report COVID-19 and other coronavirus related risks, or the presence of other virus, pathogens, and biomarkers.

Classification kind code

Class [042]
Platform as a service (PAAS) featuring computer software platforms for use in the workplace to record, monitor, track and report COVID-19 and other coronavirus related risks, or the presence of other virus, pathogens, and biomarkers.

Classification kind code

Mark Details

Serial Number

2091428

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 31^st Oct 2024	Search Recorded
Submitted for opposition 20 on 31^st Oct 2024	Examiner's First Report
Submitted for opposition 287 on 29^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 11^th Mar 2021	Filed
Submitted for opposition 1 on 11^th Mar 2021	Created
Submitted for opposition 31 on 11^th Mar 2021	Formalized

GEMINA TESTPOINT

Classification Information

Class [009]Computer software for use in the workplace to record, monitor, track and report COVID-19 and other coronavirus related risks, or the presence of other virus, pathogens, and biomarkers.

Classification kind code

Class [042]Platform as a service (PAAS) featuring computer software platforms for use in the workplace to record, monitor, track and report COVID-19 and other coronavirus related risks, or the presence of other virus, pathogens, and biomarkers.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [009]
Computer software for use in the workplace to record, monitor, track and report COVID-19 and other coronavirus related risks, or the presence of other virus, pathogens, and biomarkers.

Class [042]
Platform as a service (PAAS) featuring computer software platforms for use in the workplace to record, monitor, track and report COVID-19 and other coronavirus related risks, or the presence of other virus, pathogens, and biomarkers.